Dr. Cohen is a Senior Advisor to TPG where he was a Partner and co-founder of TPG Biotech. He currently serves as the Chairman of Monograph Capital Partners, a life sciences venture capital group. Prior to TPG, Dr. Cohen was a Professor of Medicine and Pharmacology at UCSF. He has extensive experience in biotechnology investing and governance, and has served on the boards of multiple biotechnology and pharmaceutical companies, including Quintiles Transnational (NYSE: Q), Progyny (NASDAQ: PGNY), Aptalis and BioCryst Pharmaceuticals (NASDAQ: BCRX). He currently serves on the boards of CareDx (NASDAQ: CDNA), Intellia (NASDAQ: NTLA) and Kyverna Therapeutics (NASDAQ: KVTX)